Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
470.60    0.60 (0.13%)
Bid:
469.80
Ask:
470.20
Spread: 0.40 (0.085%)
Market Cap: £2.43b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

First Quarter Trading Update

24 Jul 2019 07:00

RNS Number : 4893G
QinetiQ Group plc
24 July 2019
 

QinetiQ Group plc

First Quarter Trading Update

24 July 2019 - QinetiQ Group plc (QinetiQ or the Group) today issues a trading update covering its first quarter of trading.

Maintaining full year expectations

We have made a good start to the new financial year with strong operational performance across the Group. Revenue under contract is now 85%, up from 74% in April 2019 and we are on track to deliver mid-single digit revenue growth this year. Overall, we are reiterating expectations for Group performance in FY20 as set out in our FY19 results statement, with revenue growth at stable margins delivering continued operating profit progression excluding non-recurring trading items.

EMEA Services

In EMEA Services, we have continued to deliver on our growth strategy with orders and revenue in the quarter ahead of the prior year at expected margins. This growth was driven by good performance across the division, particularly in our Cyber Information & Training business.

Global Products

Our Global Products division has also performed well in the first quarter with orders, revenue and operating profit all ahead of the prior year, driven by good performance in all of our core product businesses, particularly QinetiQ North America.

Strategy Update

Our strategy to focus on our customers' needs and grow the company, whilst enhancing returns for shareholders, continues to gather momentum. In the first quarter, we have delivered a number of milestones that demonstrate progress in leveraging investments in our core capabilities, such as the recently renegotiated Long Term Partnering Agreement (LTPA) contract with the UK MOD, and the acquisitions of QinetiQ Germany and QinetiQ Target Systems. We continue to pursue strategy-led investments in further organic opportunities and complementary acquisitions to drive sustainable growth in the years ahead.

We are building on our commitment to lead and modernise UK test and evaluation:

·;

Exercise Formidable Shield 2019, one of the world's largest maritime live-fire integrated air and missile defence exercises was delivered at the Hebrides range that we operate on behalf of the UK Ministry of Defence (MOD). Ships from Canada, Denmark, France, Italy, the Netherlands, Norway, Spain, the United Kingdom, and the United States participated in more than a dozen successful live-fire and simulated engagements against subsonic, supersonic, and ballistic targets. This exercise was enabled by our recent investment in the LTPA contract, through the air range modernisation programme.

 

·;

We delivered the first major milestone of the renegotiated LTPA contract, achieving initial operating capability on schedule for the UK MOD, which demonstrates that we are meeting our customers' performance requirements and successfully transitioning to the new ways of working.

 

·;

Building on the renegotiated LTPA, we secured a £19m, nine-year contract to modernise and deliver acoustic and electromagnetic signature measurement and analysis services. These services are critical to enhancing the operational advantage of Royal Navy warships and submarines by decreasing their chances of detection.

 

We have made further progress in becoming a more international company:

·;

Following our successful competitive win of the Common Robotic System Individual (CRS-I) program of record from the US Department of Defense in March 2019, we have delivered the first robots on schedule under the Low Rate Initial Production (LRIP) phase. Through the CRS-I program we will be delivering up to 3,000 advanced back-packable ground robots to the US Army over the next seven years.

 

·;

As part of the LTPA air range modernisation programme contracted in 2016, QinetiQ Germany has secured a €10m contract to provide range clearance services in the UK over the next nine years. These services will leverage our acquisition of QinetiQ Germany by utilising our fleet of PC-12 aircraft configured as maritime patrol aircraft.

 

We are also advancing both our commercial and technical innovation to meet our customers' needs:

·;

In October 2018, we signed a ten-year framework contract to be the Engineering Delivery Partner (EDP) to the UK MOD's procurement agency DE&S, leading a supply chain of more than 120 companies through which we have now secured over £100m of tasking orders.

 

·;

We are successfully leveraging our acquisition of QinetiQ Target Systems, with the integration for the Royal Navy of the new Rattler supersonic target into UK ranges we operate under the LTPA. We are also undertaking final flight-testing of the completely re-designed Banshee Next Generation (NG) aerial target as part of our continued investment in the future generation of unmanned aerial systems.

 

AGM

QinetiQ's 2019 Annual General Meeting (AGM) will be held at 11am today at the offices of Ashurst LLP, Fruit and Wool Exchange, 1 Duval Square, London, E1 6PQ.

About QinetiQ:

QinetiQ (QQ.L) is a leading science and engineering company operating primarily in the defence, security and critical infrastructure markets. We work in partnership with our customers to solve real world problems through innovative solutions delivering operational and competitive advantage. Visit our website www.QinetiQ.com. Follow us on LinkedIn and Twitter @QinetiQ. Visit our blog www.QinetiQ-blogs.com.

For further information please contact:

David Bishop, Group Director Investor Relations and Communications:

+44 (0) 7920 108675

Ian Brown, Group Head of Investor Relations:

+44 (0) 7908 251123

QinetiQ press office:

+44 (0) 1252 393500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTVXLFLKDFZBBE
Date   Source Headline
2nd Jun 20266:00 pmRNSHolding(s) in Company
2nd Jun 20267:00 amRNSTransaction in Own Shares
29th May 20264:45 pmRNSTotal Voting Rights
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSQinetiQ Full Year Results 2026
20th May 20264:16 pmRNSHolding(s) in Company
19th May 20264:00 pmRNSHolding(s) in Company
19th May 20267:00 amRNSTransaction in Own Shares
12th May 20264:57 pmRNSDirector/PDMR Shareholding
12th May 20267:00 amRNSTransaction in Own Shares
5th May 20269:46 amRNSTransaction in Own Shares
30th Apr 20263:10 pmRNSTotal Voting Rights
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20261:38 pmRNSDirector Declaration
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 202612:00 pmRNSDirector/PDMR Shareholding
7th Apr 202610:00 amRNSTransaction in Own Shares
1st Apr 202610:00 amRNSDirector/PDMR Shareholding
31st Mar 20263:01 pmRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 202611:39 amRNSHolding(s) in Company
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 202612:30 pmRNSDirector/PDMR Shareholding
10th Mar 202612:30 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20263:30 pmRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.